Should You Buy Gilead Sciences Stock on the Dip?

Should You Buy Gilead Sciences Stock on the Dip?

Gilead had donated 1.5 million doses of remdesivir to the U.S. government as of June 30. As a result, Gilead's stock has fallen below $70 for the first time since March. Let's take a closer look at whether Gilead is worth buying today.